Visit the journal website here. Shannon, November 16, 2021 — Compuscript is delighted to announce the launch of a new academic journal, Acta Materia Medica. Acta Materia Medica provides an open ...

Announcing a new publication for Acta Materia Medica journal. Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based on immunotherapy, which exerts its effects by ...

Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global life sciences market, announced today that Jiangsu Provincial Institute of Materia Medica (JPIMM), has ...